Assessing Risk

As researchers use ever more sophisticated technology to create a growing list of drugs, vaccines, foods, and devices, potential risks stalk the process. With print and electronic media prodding them along, scientists, policymakers, business people, and the public have to consider the downside of inventions as well as the benefits. Headlines continually trumpet health risks--fluoridation caught the public's eye in the 1950s with stories that the procedure could rot teeth and cause cancer. Today

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Headlines continually trumpet health risks--fluoridation caught the public's eye in the 1950s with stories that the procedure could rot teeth and cause cancer. Today's headlines question whether cholesterol-fighting drugs called statins increase the incidence of heart attacks and whether cyclooxygenase-2 inhibitors put arthritis patients at greater risk of the muscle-wasting disease rhabdomyolysis. Should millions of people taking these pharmaceuticals stop treatment? That depends on how much the possible side effects outweigh the drugs' benefits.

When it comes to risk, biotechnology and genetically modified (GM) foods are no stranger to controversy. Do taco chips made from genetically modified corn really cause immune reactions, from hives to anaphylactic shock? Will pollen from GM corn threaten non-target insects? Do GM plants endanger the environment by cross breeding with wild relatives, thereby spawning superweeds?

Most scientists would probably agree that answers to these questions, and therefore policy decisions based on them, require hard data. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Barry Palevitz

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo